SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-14-000092
Filing Date
2014-11-10
Accepted
2014-11-10 16:18:47
Documents
13
Period of Report
2014-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201411108xkdoc.htm 8-K 32378
2 PRESS RELEASE pdli-201411108xkex991.htm EX-99.1 136448
3 PRESENTATION pdli-201411108xkex992.htm EX-99.2 3900
4 INFORMATION SHEET pdli-201411108xkex993.htm EX-99.3 486446
5 pdllogo75a01a01a01a02.jpg GRAPHIC 5218
6 slide1a07.jpg GRAPHIC 129664
7 slide2a07.jpg GRAPHIC 221518
8 slide3a07.jpg GRAPHIC 100429
9 slide4a07.jpg GRAPHIC 93542
10 slide5a07.jpg GRAPHIC 123613
11 slide6a07.jpg GRAPHIC 147214
12 slide7a07.jpg GRAPHIC 145789
13 slide8a07.jpg GRAPHIC 116087
  Complete submission text file 0000882104-14-000092.txt   2153788
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 141208894
SIC: 2836 Biological Products, (No Diagnostic Substances)